Accès ouvert · CC BY

Evaluating performance of the Bioline™ HCV point-of-care test in Ghana

Article scientifique 2025 Sciences de la santé Anglais

Résumé

BACKGROUND: Hepatitis C Virus (HCV) causes liver diseases including chronic hepatitis, cirrhosis, and hepatocellular carcinoma. In low- and middle-income countries (LMICs), particularly sub-Saharan Africa (SSA), HCV diagnostic resources are limited. Moreover, most evaluations of point-of-care (POC) invitro diagnostics (IVDs) are conducted outside the region using non-African populations, which may not reflect their performance in local settings where they are mostly used. This study assessed the diagnostic performance of the Bioline™ HCV POC test in Ghanaian HCV target populations. METHODS: A cross-sectional field evaluation was conducted among HCV priority populations including incarcerated individuals, patients requiring HCV testing, and voluntary blood donors undergoing pre-donation screening. Venous blood samples were tested using the Bioline™ HCV POC test, and the results were compared with the Enzyme-Linked Immunosorbent Assay (ELISA) reference standard. The sensitivity, specificity, test efficiency, Youden index, predictive values, likelihood ratios, and receiver operating characteristic (ROC) indicators were calculated. RESULTS: The Bioline™ HCV POC test demonstrated a sensitivity of 96.7% (95% CI: 82.8-99.9%), specificity of 99.8% (95% CI: 98.9-100%), and positive and negative predictive values of 96.7% (95% CI: 82.8-99.9%) and 99.8% (95% CI: 98.9-100%), respectively. The test efficiency was 99.6% (98.6-99.9%), Youden index 0.97 (0.82-0.99) with a ROC area of 0.98 and highly favorable likelihood ratios (LR + 483.5, LR - 0.03). CONCLUSION: This study highlights the high diagnostic performance of the Bioline™ HCV POC test in Ghanaian populations. The test's reliability underscores its potential as a valuable tool for HCV screening and early detection in resource-limited settings, contributing to efforts to reduce the global HCV burden. TRIAL REGISTRATION: This study is part of a diagnostic trial registered in the Pan African Clinical Trial Registry ( https://pactr.samrc.ac.za ) on 24th October 2024 with trial registration number: PACTR202410837698664.

Citer ce document

Duah, E., Mathebula, E. M., Maluleke, K., Azumah, D. E., Ephraim, R. K. D., & Mashamba-Thompson, T. P. (2025). Evaluating performance of the Bioline™ HCV point-of-care test in Ghana. BMC Infectious Diseases. https://doi.org/10.1186/s12879-025-11730-8

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 29/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 11

Téléchargements (hors robots) : 0

Méthode de comptage